asa statement on glp 1 GLP-1 RA guidance roundup Perioperative management of patients taking

Description

doi: 10.1586/1744666x.2013.848793 88 ChenTTianPHuangZZhaoXWangHXiaCet al

14 Recommendations The results above have prompted the ADA and EASD to recommend GLP-1RAs as preferred second- or third-line injectable agents following metformin in people with: 1 established atherosclerotic cardiovascular disease a need to minimise weight gain or promote weight loss a need to minimise hypoglycaemia mild-to-moderate chronic kidney disease

Furthermore, the explosive demand we've witnessed through 2025 and into 2026 has created a perfect storm

Participants reported drinking less, experienced fewer effects of alcohol when they did drink it, and decreased odds of binge drinking, co-author Alexandra DiFeliceantonio, an assistant professor at Fralin Biomedical Research Institute, said in the news release